HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutation S233L in the 1B domain of keratin 1 causes epidermolytic palmoplantar keratoderma with "tonotubular" keratin.

Abstract
Epidermolytic palmoplantar keratoderma (EPPK) is an autosomal dominant genodermatosis characterized by epidermolytic hyperkeratosis restricted to the palm and sole epidermis. The disorder is normally associated with dominant-negative mutations in the keratin 9 (K9) gene; however, a small number of cases have been reported where causative mutations were identified in the K1 gene. Here, we present two unrelated Dutch EPPK families with striking ultrastructural findings: tubular keratin structures in the cytoplasm of suprabasal cells. Similar structures were reported previously in a German EPPK family and were termed "tonotubular" keratin. After excluding the involvement of the K9 gene by complete sequencing, we identified a novel mutation, S233L, at the beginning of the 1B domain of K1 in both families. Protein expression studies in cultured cells indicated pathogenicity of this mutation. This is the first report of a genetic defect in this domain of K1. The unusual gain-of-function mutation points to a subtle role of the 1B domain in mediating filament-filament interactions with regular periodicity.
AuthorsAna Terron-Kwiatkowski, Maurice A M van Steensel, Michel van Geel, E Birgitte Lane, W H Irwin McLean, Peter M Steijlen
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 126 Issue 3 Pg. 607-13 (Mar 2006) ISSN: 0022-202X [Print] United States
PMID16439967 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • KRT1 protein, human
  • Keratin-1
  • Keratins
Topics
  • Humans
  • Keratin-1
  • Keratins (chemistry, genetics)
  • Keratoderma, Palmoplantar (genetics, pathology)
  • Microscopy, Electron
  • Mutation
  • Protein Structure, Tertiary

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: